Interleukin-11 Overexpression and M2 Macrophage Density are Associated with Angiogenic Activity in Proliferative Diabetic Retinopathy

References

• Abu El-Asrar AM, De Hertogh G, Van Den Eynde K, et al. Myofibroblasts in proliferative diabetic retinopathy can originate from infiltrating fibrocytes and through endothelial-to-mesenchymal transition (EndoMT). Exp Eye Res. 2015;132:179–189. doi:10.1016/j.exer.2015.01.023.
   PubMed Web of Science ®Google Scholar
• El-Asrar AM, Missotten L, Geboes K. Expression of high-mobility groups box-1/receptor for advanced glycation end products/osteopontin/early growth response-1 pathway in proliferative vitreoretinal epiretinal membranes. Mol Vis. 2011;17:508–518.
   PubMed Web of Science ®Google Scholar
• Nawaz MI, Van Raemdonck K, Mohammad G, et al. Autocrine CCL2, CXCL4, CXCL9 and CXCL10 signal in retinal endothelial cells and are enhanced in diabetic retinopathy. Exp Eye Res. 2013;109:67–76. doi:10.1016/j.exer.2013.01.008.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Mohammad G, Nawaz MI, et al. Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathy. PLoS One. 2013;8(12):e85857. doi:10.1371/journal.pone.0085857.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Struyf S, Mohammad G, et al. Osteoprotegerin is a new regulator of inflammation and angiogenesis in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2017;58:3189–3201. doi:10.1167/iovs.16-20993.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Nawaz MI, De Hertogh G, et al. S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis. Mol Vis. 2014;20:1209–1224.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Alam K, Nawaz MI, et al. Upregulated expression of heparanase in the vitreous of patients with proliferative diabetic retinopathy originates from activated endothelial cells and leukocytes. Invest Ophthalmol Vis Sci. 2015;56:8239–8247. doi:10.1167/iovs.15-18025.
   PubMed Web of Science ®Google Scholar
• El-Asrar AM, Nawaz MI, Kangave D, et al. High-mobility group box-1and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy. Mol Vis. 2011;17:1829–1838.
   PubMed Web of Science ®Google Scholar
• Kim YW, West XZ, Byzova TV. Inflammation and oxidative stress in angiogenesis and vascular disease. J Mol Med (Berl). 2013;91:323–328. doi:10.1007/s00109-013-1007-3.
   PubMed Web of Science ®Google Scholar
• Ono M. Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci. 2008;99:1501–1506. doi:10.1111/j.1349-7006.2008.00853.x.
   PubMed Web of Science ®Google Scholar
• Murakami M, Kamimura D, Hirano T. New IL-6 (gp130) family cytokine members, CLC/NNT1/BSF3 and IL-27. Growth Factors. 2004;22:75–77.
   PubMed Web of Science ®Google Scholar
• Kishimoto T, Akira S, Narazaki M, Taga T. Interleukin-6 family of cytokines and gp130. Blood. 1995;86:1243–1254.
   PubMed Web of Science ®Google Scholar
• Permyakov EA, Uversky VN, Permyakov SE. Interleukin-11: a multifunctional cytokine with intrinsically disordered regions. Cell Biochem Biophys. 2016;74:285–296. doi:10.1007/s12013-016-0752-7.
   PubMed Web of Science ®Google Scholar
• Putoczki TL, Thiem S, Loving A, et al. Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically. Cancer Cell. 2013;24:257–271. doi:10.1016/j.ccr.2013.06.017.
   PubMed Web of Science ®Google Scholar
• Johnstone CN, Chand A, Putoczki TL, Ernst M. Emerging roles for IL-11 signaling in cancer development and progression: focus on breast cancer. Cytokine Growth Factor Rev. 2015;26:489–498. doi:10.1016/j.cytogfr.2015.07.015.
   PubMed Web of Science ®Google Scholar
• Putoczki T, Ernst M. More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer. J Leukoc Biol. 2010;88:1109–1117. doi:10.1189/jlb.0410226.
   PubMed Web of Science ®Google Scholar
• Taniguchi K, Karin M. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Semin Immunol. 2014;26:54–74. doi:10.1016/j.smim.2014.01.001.
   PubMed Web of Science ®Google Scholar
• Xu DH, Zhu Z, Wakefield MR, Xiao H, Bai Q, Fang Y. The role of IL-11 in immunity and cancer. Cancer Lett. 2016;373:156–163. doi:10.1016/j.canlet.2016.01.004.
   PubMed Web of Science ®Google Scholar
• Zhang X, Tao Y, Chopra M, et al. IL-11 induces Th17 cell responses in patients with early relapsing-remitting multiple sclerosis. J Immunol. 2015;194:5139–5149. doi:10.4049/jimmunol.1401680.
   PubMed Web of Science ®Google Scholar
• Elshabrawy HA, Volin MV, Essani AB, et al. IL- 11 facilitates a novel connection between RA joint fibroblasts and endothelial cells. Angiogenesis. 2018;21:215–228. doi:10.1007/s10456-017-9589-y.
   PubMed Web of Science ®Google Scholar
• Okamoto H, Yamamura M, Morita Y, Harada S, Makino H, Ota Z. The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis. Arthritis Rheum. 1997;40:1096–1105. doi:10.1002/1529-0131(199706)40:6<1096::AID-ART13>3.0.CO;2-D.
   PubMed Web of Science ®Google Scholar
• Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3:23–35. doi:10.1038/nri978.
   PubMed Web of Science ®Google Scholar
• Jetten N, Verbruggen S, Gijbels MJ, Post MJ, De Winther MP, Donners MM. Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis. 2014;17:109–118. doi:10.1007/s10456-013-9381-6.
   PubMed Web of Science ®Google Scholar
• Wang FQ, Chen G, Zhu JY, et al. M2-polarised macrophages in infantile haemangiomas: correlation with promoted angiogenesis. J Clin Pathol. 2013;66:1058–1064. doi:10.1136/jclinpath-2012-201286.
   PubMed Web of Science ®Google Scholar
• Zhong WQ, Chen G, Zhang W, et al. M2-polarized macrophages in keratocystic odontogenic tumor: relation to tumor angiogenesis. Sci Rep. 2015;5:15586. doi:10.1038/srep15586.
   PubMed Web of Science ®Google Scholar
• Obeid E, Nanda R, Fu YX, Olopade OI. The role of tumor-associated macrophages in breast cancer progression (review). Int J Oncol. 2013;43:5–12. doi:10.3892/ijo.2013.1938.
   PubMed Web of Science ®Google Scholar
• Genard G, Lucas S, Michiels C. Reprogramming of tumor-associated macrophages with anticancer therapies: radiotherapy versus chemo- and immunotherapies. Front Immunol. 2017;8:828. doi:10.3389/fimmu.2017.00828.
   PubMed Web of Science ®Google Scholar
• Ambarus CA, Krausz S, van Eijk M, et al. Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. J Immunol Methods. 2012;375:196–206. doi:10.1016/j.jim.2011.10.013.
   PubMed Web of Science ®Google Scholar
• Etzerodt A, Maniecki MB, Møller K, Møller HJ, Moestrup SK. Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163. J Leukoc Biol. 2010;88:1201–1205. doi:10.1189/jlb.0410235.
   PubMed Web of Science ®Google Scholar
• Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480–1487. doi:10.1056/NEJM199412013312203.
   PubMed Web of Science ®Google Scholar
• Hlatky L, Hahnfeldt P, Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn’t tell us. J Natl Cancer Inst. 2002;94:883–893.
   PubMed Web of Science ®Google Scholar
• Atanasov G, Pötner C, Aust G, et al. TIE2-expressing monocytes and M2-polarized macrophages impact survival and correlate with angiogenesis in adenocarcinoma of the pancreas. Oncotarget. 2018;9:29715–29726. doi:10.18632/oncotarget.25690.
   PubMedGoogle Scholar
• Park JY, Sung JY, Lee J, et al. Polarized CD163+ tumor-associated macrophages are associated with increased angiogenesis and CXCL12 expression in gastric cancer. Clin Res Hepatol Gastroenterol. 2016;40:357–365. doi:10.1016/j.clinre.2015.09.005.
   PubMed Web of Science ®Google Scholar
• Hu JM, Liu K, Liu JH, et al. CD163 as a marker of M2 macrophage, contributes to predict aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma. Oncotarget. 2017;8:21526–21538. doi:10.18632/oncotarget.15630.
   PubMedGoogle Scholar
• Takeuchi H, Tanaka M, Tanaka A, Tsunemi A, Yamamoto H. Predominance of M2-polarized macrophages in bladder cancer affects angiogenesis, tumor grade and invasiveness. Oncol Lett. 2016;11:3403–3408. doi:10.3892/ol.2016.4392.
   PubMed Web of Science ®Google Scholar
• Chu Q, Zhang J, Wu Y, et al. Differential gene expression pattern of diabetic rat retinas after intravitreal injection of erythropoietin. Clin Exp Ophthalmol. 2011;39:142–151.
   PubMed Web of Science ®Google Scholar
• Lokau J, Nitz R, Agthe M, et al. Proteolytic cleavage governs interleukin-11 trans-signaling. Cell Rep. 2016;14:1761–1773. doi:10.1016/j.celrep.2016.01.053.
   PubMed Web of Science ®Google Scholar
• Tang W, Geba GP, Zheng T, et al. Targeting expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction. J Clin Invest. 1996;98:2845–2853. doi:10.1172/JCI119113.
   PubMed Web of Science ®Google Scholar
• Kapina MA, Shepelkova GS, Avdeenko VG, et al. Interleukin-11 drives early lung inflammation during mycobacterium tuberculosis infection in genetically susceptible mice. PLoS One. 2011;6:e21878. doi:10.1371/journal.pone.0021878.
   PubMed Web of Science ®Google Scholar
• Wong PK, Campbell IK, Robb L, Wicks IP. Endogenous IL-11 is pro-inflammatory in acute methylated bovine serum albumin/interleukin-1-induced (mBSA/IL-1)arthritis. Cytokine. 2005;29:72–76. doi:10.1016/j.cyto.2004.09.011.
   PubMed Web of Science ®Google Scholar
• Spranger J, Pfeiffer AF. New concepts in pathogenesis and treatment of diabetic retinopathy. Exp Clin Endocrinol Diabetes. 2001;109(Suppl 2):S438–S450. doi:10.1055/s-2001-18601.
   PubMedGoogle Scholar
• Bringmann A, Pannicke T, Grosche J, et al. Müller cells in the healthy and diseased retina. Prog Retin Eye Res. 2006;25:397–424. doi:10.1016/j.preteyeres.2006.05.003.
   PubMed Web of Science ®Google Scholar
• Shima DT, Adamis AP, Ferrara N, et al. Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med. 1995;1:182–193.
   PubMed Web of Science ®Google Scholar
• Stone J, Itin A, Alon T, et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 1995;15(7 Pt 1):4738–4747.
   PubMed Web of Science ®Google Scholar
• Zhao M, Liu Y, Liu R, et al. Upregulation of IL-11, an IL-6 family cytokine, promotes tumor progression and correlates with poor prognosis in non-small cell lung cancer. Cell Physiol Biochem. 2018;45:2213–2224. doi:10.1159/000488166.
   PubMedGoogle Scholar
• Zhong Z, Hu Z, Jiang Y, et al. Interleukin-11 promotes epithelial-mesenchymal transition in anaplastic thyroid carcinoma cells through PI3K/Akt/GSK3β signaling pathway activation. Oncotarget. 2016;7:59652–59663. doi:10.18632/oncotarget.10831.
   PubMedGoogle Scholar
• Onnis B, Fer N, Rapisarda A, Perez VS, Melillo G. Autocrine production of IL-11 mediates tumorigenicity in hypoxic cancer cells. J Clin Invest. 2013;123:1615–1629. doi:10.1172/JCI59623.
   PubMed Web of Science ®Google Scholar
• Powis G, Kirkpatrick L. Hypoxia inducible factor-1alpha as a cancer drug target. Mol Cancer Ther. 2004;3:647–654.
   PubMed Web of Science ®Google Scholar
• Li SH, Shin DH, Chun YS, Lee MK, Kim MS, Park JW. A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1{alpha}. Mol Cancer Ther. 2008;7:3729–3738. doi:10.1158/1535-7163.MCT-08-0074.
   PubMed Web of Science ®Google Scholar
• Yeo EJ, Chun YS, Park JW. New anticancer strategies targeting HIF-1. Biochem Pharmacol. 2004;68:1061–1069. doi:10.1016/j.bcp.2004.02.040.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Yoshida S, Nakama T, et al. Overexpression of CD163 in vitreous and fibrovascular membranes of patients with proliferative diabetic retinopathy: possible involvement of periostin. Br J Ophthalmol. 2015;99:451–456. doi:10.1136/bjophthalmol-2014-305321.
   PubMed Web of Science ®Google Scholar
• Yoshida S, Kobayashi Y, Nakama T, et al. Increased expression of M-CSF and IL-13 in vitreous of patients with proliferative diabetic retinopathy: implications for M2 macrophage-involving fibrovascular membrane formation. Br J Ophthalmol. 2015;99:629–634. doi:10.1136/bjophthalmol-2014-305860.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Zhang D, Gong B, Wang P, Liu F. CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer. Oncotarget. 2017;8:87244–87262. doi:10.18632/oncotarget.20244.
   PubMedGoogle Scholar
• Maniecki MB, Etzerodt A, Ulhøi BP, et al. Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells. Int J Cancer. 2012;131:2320–2331. doi:10.1002/ijc.27506.
   PubMed Web of Science ®Google Scholar
• Urbich C, De Souza AI, Rossig L, et al. Proteomic characterization of human early pro-angiogenic cells. J Mol Cell Cardiol. 2011;50:333–336. doi:10.1016/j.yjmcc.2010.11.022.
   PubMed Web of Science ®Google Scholar
• Shi Y, Kramer G, Schröder A, et al. Early endothelial progenitor cells as a source of myeloid cells to improve the pre-vascularisation of bone constructs. Eur Cell Mater. 2014;27:64–80.
   PubMed Web of Science ®Google Scholar
• Lu W, Su L, Yu Z, Zhang S, Miao J. The new role of CD163 in the differentiation of bone marrow stromal cells into vascular endothelial-like cells. Stem Cells Int. 2016;2016:2539781. doi:10.1155/2016/2539781.
   PubMed Web of Science ®Google Scholar
• Bianchetti L, Barczyk M, Cardoso J, Schmidt M, Bellini A, Mattoli S. Extracellular matrix remodelling properties of human fibrocytes. J Cell Mol Med. 2012;16:483–495. doi:10.1111/j.1582-4934.2011.01344.x.
   PubMed Web of Science ®Google Scholar
• Kim JS, Romero R, Tarca AL, et al. Gene expression profiling demonstrates a novel role for foetal fibrocytes and the umbilical vessels in human fetoplacental development. J Cell Mol Med. 2008;12:1317–1330. doi:10.1111/j.1582-4934.2008.00284.x.
   PubMed Web of Science ®Google Scholar
• Kim SS, Romero R, Kim JS, et al. Coexpression of myofibroblast and macrophage markers: novel evidence for an in vivo plasticity of chorioamniotic mesodermal cells of the human placenta. Lab Invest. 2008;88:365–374. doi:10.1038/labinvest.3700749.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Struyf S, Opdenakker G, Van Damme J, Geboes K. Expression of stem cell factor/c-kit signaling pathway components in diabetic epiretinal fibrovascular membranes. Mol Vis. 2010;16:1098–1107.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Struyf S, Verbeke H, Van Damme J, Geboes K. Circulating bone-marrow-derived endothelial precursor cells contribute to neovascularization in diabetic epiretinal membranes. Acta Ophthalmol. 2011;89:222–228.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Struyf S, Van Damme J, Geboes K. Circulating fibrocytes contribute to the myofibroblast population in proliferative vitreoretinopathy epiretinal membranes. Br J Ophthalmol. 2008;92:699–704. doi:10.1136/bjo.2007.134346.
   PubMed Web of Science ®Google Scholar
• Chai EZ, Shanmugam MK, Arfuso F, et al. Targeting transcription factor STAT3 for cancer prevention and therapy. Pharmacol Ther. 2016;162:86–97. doi:10.1016/j.pharmthera.2015.10.004.
   PubMed Web of Science ®Google Scholar
• Vanlandingham PA, Nuno DJ, Quiambao AB, et al. Inhibition of Stat3 by a small molecule inhibitor slows vision loss in a rat model of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2017;58:2095–2105. doi:10.1167/iovs.16-20641.
   PubMed Web of Science ®Google Scholar
• Fu XL, Duan W, Su CY, et al. Interleukin 6 induces M2 macrophage differentiation by STAT3 activation that correlates with gastric cancer progression. Cancer Immunol Immunother. 2017;66:1597–1608. doi:10.1007/s00262-017-2052-5.
   PubMed Web of Science ®Google Scholar
• Yeo EJ, Chun YS, Cho YS, et al. YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. J Natl Cancer Inst. 2003;95:516–525.
   PubMed Web of Science ®Google Scholar
• Schafer S, Viswanathan S, Widjaja AA, et al. IL-11 is a crucial determinant of cardiovascular fibrosis. Nature. 2017;552:110–115. doi:10.1038/nature24676.
   PubMed Web of Science ®Google Scholar